Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. The company aims to build one of the broadest pipelines of pain therapeutics, combining its management team's expertise in pain biology, clinical translation, and trial execution. Its leadership team includes seasoned executives with track records for translating scientific discoveries into successful global drug approvals.

Latigo Biotherapeutics is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. The company aims to build one of the broadest pipelines of pain therapeutics, which it believes, combined with its management team's deep expertise in pain biology, clinical translation, and trial execution, positions it to deliver meaningful patient benefit and to change the current treatment paradigm of pain medicines.

Positioning itself to change the treatment paradigm of pain medicines by providing effective, rapid-acting pain relief without the risk of addiction.

1. 1home - Latigo Biotherapeuticslatigobio.com
2. 2About - Latigo Biotherapeuticslatigobio.com